Skip to content
Wednesday, November 18, 2026
Discover Grand Royal Express for top-tier luxury travel sol…

Zimbabwe Rejects ‘Lopsided’ American Health Aid Agreement Over Information Concerns

Health funding illustration
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, TB, and malarial diseases.

The nation of Zimbabwe has rejected a major US healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's insistence on sensitive biological samples.

This rejection came to light following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "unbalanced".

A government representative later stated that the US was requesting biological samples for research and commercial gain but was unwilling to guarantee the benefits from any future medical innovations.

"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe during the past two decades.

A physicians' group in Zimbabwe has called for more negotiations to reach a deal agreeable to all parties so the country's critical HIV programme can proceed.

Wider Context

This development comes after a comparable situation in neighbouring Kenya, where a high court blocked a similar health funding agreement after concerns were raised about the security of Kenyans' medical information.

Since returning to office last year, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had administered aid for the US government, but Trump claimed its expenditure was "wasteful" and his government was pursuing government-to-government deals to enhance transparency and responsibility.

Based on statements, 16 nations in Africa have so far agreed to similar agreements, constituting more than $18.3bn of fresh investment.

Specifics of the Rejected Deal

The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We believe this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million presently on antiretroviral therapy through American-funded programmes," Tremont commented.

However, government spokesperson Nick Mangwana said the proposed deal was "unequal".

"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, without any corresponding promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that provided information," Mangwana explained.

"In essence, our country would supply the raw materials for medical research with no assurance that the resulting innovations would be accessible to our citizens should a future pandemic emerge."

National Interest and Global Health

Mangwana further said that the American exit from the World Health Organization (WHO) and its pursuit of one-on-one deals were upending structures previously set up via the global organization.

The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with future pandemics.

"This system is designed to ensure that when a nation contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."

The government's concerns over the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We welcome ongoing discussions with our US partners on how future collaboration could be structured in a manner that respects the independence and dignity of each country."

Health Experts Response

Medical experts stated it recognised the official position, but suggested that negotiations should continue since much of the country's HIV programmes depended on international support.

"In cases where technical issues exist, such as those involving information security or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," the group added.

The situation underscores the continuing tensions between accepting much-needed international aid and protecting local interests in an ever more interconnected world.

By

Alexis Beck

A seasoned travel journalist with over a decade of experience covering luxury destinations and premium transportation trends globally.

Grand Royal Express

Type to search articles.